Open House Biologics Discount Agreement for Follitropin delta
Oryginalny tytuł ogłoszenia
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2025-07 - Follitropin delta
Ocena szansy
Skąd ta ocena?
Szansa
62 / 100
Złożoność
58 / 100
Czynniki ryzyka
The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...
Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...
Submission deadline in 5 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Przegląd
Moderate opportunityKluczowe fakty
- Supplies contract
- 1 lot
- Duration until Jun 2026
- Open House discount agreements for pharmaceutical products, specifically Follitropin delta.
- Nationwide performance in Germany.
Pokaż pełne podsumowanie
Open House supply arrangement by Techniker Krankenkasse for the active substance Follitropin delta (CPV 33600000). The procedure is non-exclusive, with no individual negotiations and uniform terms. Participation is open throughout the contract period, but the notice states the procedure will end early on 30.08.2026 and a follow-on procedure will be launched. Procurement documents are available online, but no separate procurement document text was provided for analysis beyond the XML notice extract.
Ryzyka
The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...
Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...
Submission deadline in 5 days
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Technical
- Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the relevant medicinal product.
- Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
- Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.
Zamawiający
Lokalizacja
Hamburg, DEU
Strona
Identyfikator
992-80116-93
Działalność
Health
Części (1)
LOT-0001
Open House Biologics Discount Agreement for Follitropin delta
Supply lot for discount agreements under § 130a(8) SGB V concerning Follitropin delta. The lot is nationwide in Germany and follows Open House terms with no exclusivity and no individual negotiation. The XML notice indicates the procedure will end early on 30.08.2026, although the structured data also states a maximum contract term ending 31.05.2027; this inconsistency affects timing and should be clarified.
Lokalizacja
Czas trwania
Kategoria
Termin
Szczegóły kryteriów
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin delta zu schließen.
Uwaga do wartości
Pokaż oryginalne dane TED
Oryginalny tytuł części
Open House Biologika Rabattverträge 2025-07 - Follitropin delta
Oryginalny opis TED
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin delta zu schließen.
Szczegóły zamówienia
- Data publikacji
- 08 Jul 2026
- Języki
- German
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 474600-2026
Dokumenty (1)
Podobne przetargi
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Ocena szansy
Skąd ta ocena?
Szansa
62 / 100
Złożoność
58 / 100
Czynniki ryzyka
The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...
Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...
Submission deadline in 5 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications